Glenmark Pharmaceuticals Ltd Stock News
Glenmark Pharmaceuticals Ltd Share Price
Detail Overview₹2,166.60
-31.90(-1.45%)
As on 23 Oct 2026 at 15:59
As of 23 Oct 2026 at 15:59, Glenmark Pharmaceuticals Ltd is trading at ₹2,166.60. The 52-week range stands at ₹1,792.60–₹2,537.60, with a market cap of ₹60.10 thousand crore. At a P/E of 41.17 and a dividend yield of 0.23%, it is a large-cap stock in the Pharmaceuticals sector.
GLENMARK Price Chart
Market Cap
₹60.10K Cr
PE Ratio
41.17
ROCE
6.29%
Glenmark Pharmaceuticals Ltd Latest News
View More28 SEPT 2026 | Monday
Glenmark Pharmaceuticals restricts trading for insiders ahead of Q2 2026 results
22 SEPT 2026 | Tuesday
Glenmark Pharmaceuticals Ltd gains for fifth session
11 SEPT 2026 | Friday
India Ratings affirmed Glenmark Pharmaceuticals' Bank Loans with an IND AA+ stable outlook
26 AUG 2026 | Wednesday
Glenmark Pharmaceuticals Ltd spurts 1.8%, up for third straight session
10 AUG 2026 | Monday
Glenmark Pharmaceuticals allotted equity shares under ESOP 2016, raising paid-up capital
31 JUL 2026 | Friday
Immunogenics advances multispecific therapeutics with AbbVie, Glenmark collaborations, potential $1.225 billion
21 JUL 2026 | Tuesday
Glenmark receives USFDA approval for expanded use of RYALTRIS' for pediatric patients
16 JUL 2026 | Thursday
Glenmark Pharmaceuticals announces board meeting date
15 JUL 2026 | Wednesday
Glenmark Pharmaceuticals Ltd soars 0.08%, up for fifth straight session
06 JUL 2026 | Monday
Glenmark Pharmaceuticals Ltd stays supported
